These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33819510)

  • 21. Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis.
    Gane J; Buckley R
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):65-74. PubMed ID: 24229824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.
    Keklikci U; Dursun B; Cingu AK
    Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.
    Al-Amri AM; Mirza AG; Al-Hakami AM
    Middle East Afr J Ophthalmol; 2016; 23(1):135-8. PubMed ID: 26957853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials.
    Zhao M; He F; Yang Y; Lin W; Qiu W; Meng Q; Zhang J; Zhou Z
    Eur J Hosp Pharm; 2022 May; 29(3):129-133. PubMed ID: 33144336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
    Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
    Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.
    Lambiase A; Minchiotti S; Leonardi A; Secchi AG; Rolando M; Calabria G; Orsoni J; Zola E; Ferreri G; Aragona P; Reibaldi A; Chisari G; Bonini S
    Ophthalmic Epidemiol; 2009; 16(1):38-41. PubMed ID: 19191180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modern approach to managing vernal keratoconjunctivitis.
    Kumar S; Gupta N; Vivian AJ
    Curr Allergy Asthma Rep; 2010 May; 10(3):155-62. PubMed ID: 20425012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
    Oray M; Toker E
    Cornea; 2013 Aug; 32(8):1149-54. PubMed ID: 23676782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
    Samyukta SK; Pawar N; Ravindran M; Allapitchai F; Rengappa R
    J AAPOS; 2019 Feb; 23(1):36.e1-36.e5. PubMed ID: 30664932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
    Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
    Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis.
    Salami E; Righetti G; Cavarzeran F; Leonardi A
    Ocul Immunol Inflamm; 2023 Nov; 31(9):1870-1872. PubMed ID: 35914313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial.
    Eltagoury M; Abou Samra W; Ghoneim E
    Med Hypothesis Discov Innov Ophthalmol; 2022; 11(2):52-63. PubMed ID: 37641784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
    Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
    Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
    Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical tacrolimus 0.03% as sole therapy in vernal keratoconjunctivitis: a randomized double-masked study.
    Müller GG; José NK; de Castro RS
    Eye Contact Lens; 2014 Mar; 40(2):79-83. PubMed ID: 24418865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis.
    Esposito S; Fior G; Mori A; Osnaghi S; Ghiglioni D
    Paediatr Drugs; 2016 Oct; 18(5):347-55. PubMed ID: 27461427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tear Tacrolimus Levels and Clinical Response After Adjunct Therapy With Cutaneous Application of Tacrolimus 0.1% Over Upper Eyelid Skin in Chronic Vernal Keratoconjunctivitis.
    Bardoloi P; Vanathi M; Velpandian T; Laxmi M; Gupta N; Lomi N; Tandon R
    Cornea; 2024 Jul; 43(7):820-827. PubMed ID: 37921523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine.
    Modugno RL; Scalora T; Bonaldo A; Lazzarini D; Leonardi A
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1599-1605. PubMed ID: 32275180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.